Pitavastatin Impurity 106 CAS CATO-C4X-1037106
| CAS No. | CATO-C4X-1037106 |
| Molecular Formula | C26H26FNO4 |
| Molecular Weight | 435.49 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Pitavastatin Impurity 106.
CATO supplies Pitavastatin Impurity 106 (CAS CATO-C4X-1037106), a pharmacopoeial impurity reference standard (molecular formula C26H26FNO4, MW 435.49 g/mol) used for the identification and quantification of trace impurities in APIs.
Owing to a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution, Pitavastatin Impurity 106 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 435.49 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Pitavastatin Impurity 106 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C26H26FNO4 |
| Molecular Weight | 435.49 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 14.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 1 |
Related Pitavastatin Standards
- Pitavastatin Impurity 16 (CAS 849811-78-5)
- Pitavastatin Impurity 116 (CAS CATO-C4X-1037116)
- Pitavastatin Impurity 50 (CAS 1980814-87-6)
- Pitavastatin Impurity 87 (CAS 224320-09-6)
- 5-Oxo-Pitavastatin Methyl Ester (CAS 917752-45-5)
- Pitavastatin Impurity 51 (CAS 1187966-93-3)
- Pitavastatin Impurity 135 (CAS CATO-C4X-1037135)
- Pitavastatin 3-Oxo Ethyl Ester (CAS 148901-69-3)
Recommended Standards
- Dacomitinib Impurity 34 (CAS CATO-C4X-208634)
- Fosinopril EP Impurity A (CAS 95399-71-6)
- Tert-butyl benzyl(2-((2-nitrophenyl)sulfonamido)ethyl)carbamate (CAS 2726445-73-2)
- 2,5-Bis(butyltellanyl)furan (CAS 543692-18-8)
- Ruxolitinib Impurity 64 (CAS CATO-C4X-205864)
- Ceritinib Impurity 13 (CAS CATO-C4X-104813)
- Phenylephrine Impurity 86 (CAS CATO-C4X-146786)
- 3-Oxa-7-azabicyclo[3.3.1]Nonan-9-ol acetate (CAS 1443980-27-5)
- 1-(4-(Cyanomethyl)phenyl)-4-hydroxy-2-oxo-1,2,5,6-tetrahydropyridine-3-carbonitrile (CAS 1956371-66-6)
- 1-Benzyl-4-hydroxypiperidine-4-carboxylic acid hydrochloride (CAS 1262988-77-1)
- N-(5-(((2-Oxooxazolidin-3-yl)imino)methyl)furan-2-yl)acetamide (CAS 83796-92-3)
- Glyoxal (39% in Water, ca. 8.8mol/L) (CAS 107-22-2)
- Midazolam Impurity 14 (CAS 2531288-23-8)
- Peptide Impurity 06 (CAS CATO-CPTD788806)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com